Defining 31Phosphorous Magnetic Resonance Spectroscopy Characteristics in Patients With Mitochondrial Myopathy
Completed
Conditions studied: Mitochondrial Disease
In brief
This is a developmental protocol to determine the MRI based 31P-MRS changes seen in subjects with mitochondrial myopathy using our dynamic exercise protocol and to identify the ideal variable(s) to represent mitochondrial function.
Key facts
- Study ID
- NCT01301235
- Run by
- Massachusetts General Hospital
- People needed
- 8
- Starts
- 2011-02-01
- Expected to finish
- 2012-04-01
- Last updated by the study team
- 2012-04-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Men and women ≥ age 18 years old with primary mitochondrial myopathy
- Known alteration in electron transport chain activity (<25 % activity of ETC) or known mutations in mitochondrial gene.
You may not qualify if…
- Failure based on standard clinical MRI Screening form - the form is intended to establish the safety of subjects participating in the MRI scan without divulging any confidentiality information -
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.